Mary Clark - MergerLinks

target

Easypharm Otc

bidder

NEURAXPHARM

value n/a

13 dealmakers

Netherlands

Biotechnology

Cross BorderTender OfferPublicMajorityAcquisitionPrivate Equity

target

Kiadis Pharma

bidder

Sanofi

£276m

37 dealmakers

United States

Biotechnology

Venture CapitalAcquisitionDomesticPrivateMajorityPrivate Equity

target

Velosbio

bidder

Merck & Co

£2,116m

55 dealmakers

Switzerland

Biotechnology

Private EquityMajorityCross BorderPrivateAcquisition

target

Nbe Therapeutics

bidder

Boehringer Ingelheim

£1,066m

12 dealmakers

Netherlands

Medical Equipment

Cross BorderMinorityPrivateAcquisitionPrivate Equity

target

Salvia Bioelectronics

bidder

Dolby Family Ventures

£19m

14 dealmakers

Switzerland

Biotechnology

AcquisitionMinorityPrivatePrivate EquityCross Border

target

Chord Therapeutics

bidder

Omega Funds

£12m

15 dealmakers

United Kingdom

Pharmaceuticals

MinorityPrivate EquityAcquisitionPrivateCross BorderVenture Capital

target

Centessa Pharmaceuticals

bidder

Janus Henderson Investors

£179m

27 dealmakers

Germany

Biotechnology

AcquisitionVenture CapitalCross BorderMinorityPrivatePrivate Equity

target

AMSILK

bidder

Mig Verwaltungs

£25m

16 dealmakers

Netherlands

Biotechnology

AcquisitionPrivatePrivate EquityVenture CapitalCross BorderMinority

target

Targed Biopharmaceuticals

bidder

Utrecht Health Seed Fund

£32m

21 dealmakers

United States

Pharmaceuticals

PrivateAcquisitionMajorityDomestic

target

Villaris Therapeutics

bidder

Incyte Corporation

£340m

19 dealmakers

Denmark

Biotechnology

Private EquityAcquisitionCross BorderMinorityPrivate

target

Adcendo Aps

bidder

Pontifax Venture Capital

£33m

8 dealmakers

Identify industry experts, connect with verified professionals, forge new relationships.